Last reviewed · How we verify
NCT06596395: CAF+BJ
Effect of Acute Caffeine and Beetroot Juice Intake on Strength, Power, and Muscular Endurance
NA trial testing Acute caffeine and beetroot juice in Dietary Supplements in 14 participants. Completed in 1 May 2024.
30 January 2024
Quick facts
| Lead sponsor | University of Alcala |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | other |
| Enrollment | 14 |
| Start date | 1 September 2023 |
| Primary completion | 30 January 2024 |
| Estimated completion | 1 May 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Acute caffeine and beetroot juice
- Acute caffeine
- Acute beetroot juice
- Placebo
Conditions studied
- Dietary Supplements — all drugs for Dietary Supplements →
- Caffeine — all drugs for Caffeine →
- Nitrates — all drugs for Nitrates →
- Sports Performance — all drugs for Sports Performance →
Sponsor
University of Alcala
Who can join
Adults 18 to 35, male only, with Dietary Supplements or Caffeine. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Introduction: Several studies have evaluated and confirmed the ergogenic effect of acute caffeine and beetroot juice intake on sports performance. However, there are few studies focused on the production of strength, power, and muscle endurance, particularly when both supplements are ingested together. Objectives: Evaluate the acute effect of combined and isolated intake of caffeine and beetroot juice on the production of strength, power, and muscle endurance in young adults, analyzing the effect of circadian rhythms (morning vs. afternoon) on the exercise performed (bench press vs. squat). Methods: A total of 12 healthy and physically active participants will be recruited for the study. Through a double-blind, crossover, randomized, and controlled design, participants will ingest: a) Caffeine (3 mg/kg body mass); b) Beetroot juice (70 ml, 6.5 mmol of nitrates); c) Caffeine + Beetroot juice; d) Placebo (maltodextrin, 3 mg/kg). The supplements will be ingested 120 minutes (beetroot juice or placebo) and 60 minutes before (caffeine or placebo), the latter dissolved in 200 ml of water. After the ingestion period, strength, power, and muscle endurance will be analyzed with 1RM tests, strength and power tests at 25%, 50%, 75%, and 90% 1RM, and muscle endurance tests at 65% 1RM, in all cases for squat and bench press exercises. Additionally, dynamometry (manual and the isometric mid-thigh pull test) and vertical jump (squat jump and countermovement jump) will be analyzed. The four experimental conditions will be conducted in the morning (8:00 am to 10:00 am) and in the afternoon (4:30 pm to 6:30 pm).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Single and combined effect of beetroot juice and caffeine intake on muscular strength, power and endurance performance in resistance-trained males.
Montalvo-Alonso JJ, Del Val-Manzano M, Ferragut C, Valadés D, et al · · 2025 · cited 2× · PMID 40369047 · DOI 10.1038/s41598-025-02021-y
Verify or expand the search:
- PubMed search for NCT06596395
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dietary Supplements
Currently open trials in the same condition.
- NCT06379997 — Oral Supplementation Compared With Hyaluronic Acid Infiltration in Rotator Cuff Tendinopathies · NA · recruiting
- NCT06138106 — Developing a Nutritional Supplement to Increase Collagen Synthesis in People · NA · recruiting
Other University of Alcala trials
Trials by the same sponsor.
- NCT06599164 — Evaluation of Vastus Medialis Muscle Inhibition in Indoor Soccer Players With and Without ACL Injury · not yet recruiting
- NCT06587412 — Treatment of Lateral Epicondylalgia With Shock Waves · NA · recruiting
- NCT07333443 — Caffeine and Sport Climbing Performance · NA · completed
- NCT07015008 — Sleep and Maximal Fat Oxidation · NA · completed
- NCT06723821 — Noninvasive Neuromodulation in the Management of Post-COVID Musculoskeletal Pain · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06596395 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Alcala
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06596395.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing